Skip Navigation

Cardiovascular Research 2007 75(2):349-358; doi:10.1016/j.cardiores.2007.03.030
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Selemidis, S.
Right arrow Articles by Drummond, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Selemidis, S.
Right arrow Articles by Drummond, G. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Nitric oxide suppresses NADPH oxidase-dependent superoxide production by S-nitrosylation in human endothelial cells

Stavros Selemidisa,b,c, Gregory J. Dustinga,c,d,*, Hitesh Peshavariyaa, Barbara K. Kemp-Harperb,c and Grant R. Drummondb,c

aBernard O’Brien Institute of Microsurgery, University of Melbourne, Fitzroy, Victoria 3065, Australia
bDepartment of Pharmacology, Monash University, Clayton, Victoria 3800, Australia
cCentre for Vascular Health, Monash University, Clayton, Victoria 3800, Australia
dDepartments of Surgery and Pharmacology, University of Melbourne, Victoria 3010, Australia

* Corresponding author. Tissue Engineering, Bernard O'Brien Institute of Microsurgery, University of Melbourne, 42 Fitzroy Street, Fitzroy, Victoria 3065, Australia. Tel.: +61 3 9288 4047; fax: +61 3 9416 0926. dusting{at}unimelb.edu.au

Objective: Endothelial NADPH oxidase is a major source of superoxide in blood vessels and is implicated in the oxidative stress accompanying vascular diseases, including atherosclerosis. Here we investigate the regulation of NADPH oxidase activity by nitric oxide (NO).

Methods: Human cultured microvascular endothelial cells (HMEC-1) were treated with the NO donors, diethylenetriamine (DETA)-NONOate, S-nitroso-N-acetylpenicillamine (SNAP) or sodium nitroprusside (SNP) for 0.5–24 h. Superoxide production was measured by lucigenin chemiluminescence and dihydroethidium fluorescence, while NADPH oxidase subunit expression was measured via Western blotting. S-nitrosylation was assessed using the 2,3-diaminonapthalene (DAN) assay, and via immunoblotting with an anti-nitrosocysteine antibody.

Results: Specific siRNA reduced Nox2 and Nox4 protein expression and markedly decreased superoxide production in HMEC-1. DETA-NONOate (10–300 µmol/L) suppressed superoxide production in HMEC-1 in a concentration- and time-dependent manner, which was not entirely attributable to stoichiometric reaction with NO, for the effect was observed more than 6 h after removing DETA-NONOate from solution. Similarly, sustained attenuation of superoxide production was achieved with SNP (10–100 µmol/L) and SNAP (10–100 µmol/L). The suppressive effect of NO was not dependent on (1) the sGC/cGMP/PKG pathway, (2) peroxynitrite-formation, (3) reduced protein expression of NADPH oxidase subunits or (4) dissociation of NADPH oxidase subunits. Treatment with NO caused S-nitrosylation of the crucial organizer subunit p47phox, and de-nitrosylation with UV light restored superoxide production.

Conclusions: NO causes sustained suppression of NADPH oxidase-dependent superoxide production in human endothelial cells by S-nitrosylation of p47phox. These findings highlight a novel approach by which vascular oxidative stress might be suppressed by NO donors.

KEYWORDS Nitric oxide; Endothelium; NADPH oxidase; Oxygen radicals


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
H. E. Marshall, E. N. Potts, Z. T. Kelleher, J. S. Stamler, W. M. Foster, and R. L. Auten
Protection from Lipopolysaccharide-induced Lung Injury by Augmentation of Airway S-Nitrosothiols
Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 11 - 18.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. J. Hong and J. L. Garvin
Nitric oxide reduces flow-induced superoxide production via cGMP-dependent protein kinase in thick ascending limbs
Am J Physiol Renal Physiol, May 1, 2009; 296(5): F1061 - F1066.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. Girouard, G. Wang, E. F. Gallo, J. Anrather, P. Zhou, V. M. Pickel, and C. Iadecola
NMDA Receptor Activation Increases Free Radical Production through Nitric Oxide and NOX2
J. Neurosci., February 25, 2009; 29(8): 2545 - 2552.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Saito, A. Uppal, G. Byfield, S. Budd, and M. E. Hartnett
Activated NAD(P)H Oxidase from Supplemental Oxygen Induces Neovascularization Independent of VEGF in Retinopathy of Prematurity Model
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1591 - 1598.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.